From inflammation to cancer

Irish Journal of Medical Science

Volumn 186, Issue 1, 2017, Pages 57-62

  Korniluk, A ^a   Koper, O ^a   Kemona, H ^a   Dymicka Piekarska, V ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Acute inflammation; Adhesion molecules; Cancer; Chronic inflammation

Indexed keywords

ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; CHRONIC INFLAMMATION; DISEASE COURSE; HISTORY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MALIGNANT NEOPLASM; RESEARCH; REVIEW; TRANSFORMED CELL; TUMOR MICROENVIRONMENT; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84966430760     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-016-1464-0     Document Type: Review

References (40)

1. Virchov R (1863) Cellular pathology as based upon physiological and pathological histology. J. B. Lippincott, Philadelphia. doi:10.5962/bhl.title.32770
2. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–1659. doi:10.1056/NEJM198612253152606
3. Trinchieri G (2011) Inflammation in Cancer: a therapeutic target? Oncology (Williston Park) 25:418–420. doi:10.1016/S1470-2045(11)70203-0
4. Kołaczkowska E (2007) Acute inflammation as a beneficial process—history and recent developments. Kosmos 56:27–38
5. Scott A, Khan KM, Cook JL et al (2004) What is “inflammation”? Are we ready to move beyond Celsus? Br J Sports Med 38:248–249. doi:10.1136/bjsm.2003.011221
6. Granger DN, Senchenkova E (2010) Historical perspectives. In: Inflammation and the microcirculation, Chapt. 2. Morgan & Claypool Life Sciences, San Rafael (CA), pp 3–6. doi:10.4199/C00013ED1V01Y201006ISP008
7. Ley K (2001) History of inflammation research. In: Physiology of inflammation. Methods in Physiology Series, Chapt. 1, Oxford University Press, pp 1–10. doi:10.1007/978-1-4614-7512-5
8. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899. doi:10.1016/j.cell.2010.01.025
9. Dmitrieva OS, Shilovskiy IP, Khaitov MR et al (2016) Interleukins 1 and 6 as main mediators of inflammation and cancer. Biochemistry 81:80–90. doi:10.1134/S0006297916020024
10. Zarbock A, Ley K, McEver RP et al (2011) Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118:6743–6751. doi:10.1182/blood-2011-07-343566
11. Wedepohl S, Beceren-Braun F, Riese S et al (2012) L-selectin-a dynamic regulator of leukocyte migration. Eur J Cell Biol 91:257–264. doi:10.1016/j.ejcb.2011.02.007
12. Mann AP, Tanaka T (2011) E-selectin: its role in cancer and potential as a biomarker. Transl Med Surg 1:002. doi:10.4172/2161-1025.S1-200
13. Muller WA (2013) Getting leukocytes to the site of inflammation. Vet Pathol 50:7–22. doi:10.1177/0300985812469883
14. Zarbock A, Kempf T, Wollert KC et al (2012) Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation. J Mol Med 90:353–359. doi:10.1007/s00109-011-0835-2
15. Kim M, Carman CV, Springer TA (2003) Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301:1720–1725. doi:10.1126/science.1084174
16. Mitroulis I, Alexaki VI, Kourtzelis I et al (2015) Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther 147:123–135. doi:10.1016/j.pharmthera.2014.11.008
17. Sumagin R, Sarelius IH (2010) Intercellular adhesion molecule-1 enrichment near tricellular endothelial junctions is preferentially associated with leukocyte transmigration and signals for reorganization of these junctions to accommodate leukocyte passage. J Immunol 184:5242–5252. doi:10.4049/jimmunol.0903319
18. Schenkel AR, Mamdouh Z, Muller WA (2004) Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 5:393–400. doi:10.1038/ni1051
19. Woodfin A, Voisin MB, Beyrau M et al (2011) The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 12:761–769. doi:10.1038/ni2062
20. Muller WA (2007) PECAM: Regulating the start of diapedesis. In: Adhesion molecules: function and inhibition. Progress in inflammation research, pp 201–220. doi:10.1007/978-3-7643-7975-9-8
21. Ley K, Laudanna C, Cybulsky MI et al (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689. doi:10.1038/nri2156
22. Bixel MG, Li H, Petri B et al (2010) CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis. Blood 116:1172–1184. doi:10.1182/blood-2009-12-256388
23. Proebstl D, Voisin MB, Woodfin A et al (2012) Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 209:1219–1234. doi:10.1084/jem.20111622
24. Nagata M (2005) Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm 4:503–504. doi:10.2174/1568010054526322
25. Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–175. doi:10.1038/nri3399
26. Crusz SM, Balkwill FR (2015) Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12:584–596. doi:10.1038/nrclinonc.2015.105
27. Aggarwal BB, Sung B (2011) The relationship between inflammation and cancer is analogous to that between fuel and fire. Oncology (Williston Park) 25:414–418
28. Askeland EJ, Newton MR, O’Donnell MA et al (2012) Bladder cancer immunotherapy: BCG and beyond. Adv Urol 2012:181987. doi:10.1155/2012/181987
29. Salem ML, Attia ZI, Galal SM (2016) Acute inflammation induces immunomodulatory effects on myeloid cells associated with anti-tumor responses in a tumor mouse model. J Adv Res 7:243–253. doi:10.1016/j.jare2015.06.001
30. Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22:33–40. doi:10.1016/j.semcancer.2011.12.005
31. Eiró N, Vizoso FJ (2012) Inflammation and cancer. World J Gastrointest Surg 4:62–72. doi:10.4240/wjgs.v4.i3.62
32. Aggarwal BB, Shishodia S, Sandur SK et al (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72:1605–1621. doi:10.1016/j.bcp.2006.06.029
33. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867. doi:10.1038/nature01322
34. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444. doi:10.1038/nature07205
35. Meira LB, Bugni JM, Green SL et al (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 118:2516–2525. doi:10.1172/JCI35073
36. Okazaki IM, Kotani A, Honjo T (2007) Role of AID in tumorigenesis. Adv Immunol 94:245–273. doi:10.1016/S0065-2776(06)94008-5
37. Sakurai T, He G, Matsuzawa A et al (2008) Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14:156–165. doi:10.1016/j.ccr.2008.06.016
38. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436. doi:10.1038/nature04870
39. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24–37. doi:10.1038/nrc1782
40. Liang W, Ferrara N (2016) The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res 4:83. doi:10.1158/2326-6066.CIR-15-0313